TRAVERE THERAPEUTICS, INC. Operating Leases, Rent Expense
TRAVERE THERAPEUTICS, INC. (TVTX) reported Operating Leases, Rent Expense of $158.47 thousand for the 22-month period ending 2012-12-31, per its 10-K/A filed 2013-09-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2015-07-09
- TRAVERE THERAPEUTICS, INC. operating leases, rent expense for fiscal 2012 was $95.47K.
| Period end | Operating Leases, Rent Expense 1 month | Operating Leases, Rent Expense 10 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 22 month |
|---|---|---|---|---|
| 2012-12-31 | $95.47K 10-K/A · filed 2013-09-16 | $158.47K 10-K/A · filed 2013-09-16 | ||
| 2012-08-31 | $275.00K 10-Q/A · filed 2015-07-09 | |||
| 2011-12-31 | $63.00K 10-K/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |